Fentanyl buccal

Details

Files

Generic Name:

Fentanyl buccal

Project Status:

Complete

Therapeutic Area:

Pain (breakthrough), cancer (adults)

Manufacturer:

Teva Canada Innovation

Call for patient/clinician input open:

June 10, 2016

Brand Name:

Fentora

Project Line:

Reimbursement Review

Project Number:

SR0494-000

Call for patient/clinician input closed:

August 2, 2016

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Pain (breakthrough), cancer (adults)

Recommendation Type:

Do not reimburse

Final Recommendation:

February 21, 2017

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : June 10, 2016